Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

An internadional field study of the reliability and validity of a disease-specfic questionnanire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma

Cocks, K. ; Cohen, D. ; Wisloff, F. ; Sezerc, O. ; Lee, S. ; Hippe, E. ; Gimsing, P. ; Turesson, Ingemar LU ; Hajek, R. and Smith, A. , et al. (2007) In European Journal of Cancer 43(11). p.1670-1678
Abstract
Aim: To test the reliability, validity and sensitivity of the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-MY24 questionnaire, designed to assess the quality of life of myeloma patients with the QLQ-C30. Methods: The study was carried out through the EORTC Quality of Life Group using clinical trials in seven countries. All trials used the QLQ-C30 and QLQ-MY24 at baseline and a follow-up timepoint. Results: Two hundred and forty patients participated. The questionnaires were acceptable to patients. The hypothesised scale structure (disease symptoms, side-effects, body image and future perspective) was confirmed by multi-trait scaling, internal consistency and correlation analysis. Most scales demonstrated... (More)
Aim: To test the reliability, validity and sensitivity of the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-MY24 questionnaire, designed to assess the quality of life of myeloma patients with the QLQ-C30. Methods: The study was carried out through the EORTC Quality of Life Group using clinical trials in seven countries. All trials used the QLQ-C30 and QLQ-MY24 at baseline and a follow-up timepoint. Results: Two hundred and forty patients participated. The questionnaires were acceptable to patients. The hypothesised scale structure (disease symptoms, side-effects, body image and future perspective) was confirmed by multi-trait scaling, internal consistency and correlation analysis. Most scales demonstrated sensitivity to change and discriminated between clinically different patients. The social support scale (4 items) was removed due to observed ceiling effects. Conclusion: The final questionnaire contains 20 items, QLQ-MY20, and is a reliable and valid instrument recommended for use with the QLQ-C30 in myeloma patients. (c) 2007 Elsevier Ltd. All rights reserved. (Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
QLQ-MY24, QLQ-MY20, QLQ-C30, questionnaires, validation, quality of life, multiple myeloma
in
European Journal of Cancer
volume
43
issue
11
pages
1670 - 1678
publisher
Elsevier
external identifiers
  • wos:000249198100014
  • scopus:34447266200
ISSN
1879-0852
DOI
10.1016/j.ejca.2007.04.022
language
English
LU publication?
yes
additional info
The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Emergency medicine/Medicine/Surgery (013240200)
id
c9313456-7cbf-4c27-9ca7-320b9e93fdb5 (old id 689485)
date added to LUP
2016-04-01 11:58:29
date last changed
2022-03-20 21:33:47
@article{c9313456-7cbf-4c27-9ca7-320b9e93fdb5,
  abstract     = {{Aim: To test the reliability, validity and sensitivity of the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-MY24 questionnaire, designed to assess the quality of life of myeloma patients with the QLQ-C30. Methods: The study was carried out through the EORTC Quality of Life Group using clinical trials in seven countries. All trials used the QLQ-C30 and QLQ-MY24 at baseline and a follow-up timepoint. Results: Two hundred and forty patients participated. The questionnaires were acceptable to patients. The hypothesised scale structure (disease symptoms, side-effects, body image and future perspective) was confirmed by multi-trait scaling, internal consistency and correlation analysis. Most scales demonstrated sensitivity to change and discriminated between clinically different patients. The social support scale (4 items) was removed due to observed ceiling effects. Conclusion: The final questionnaire contains 20 items, QLQ-MY20, and is a reliable and valid instrument recommended for use with the QLQ-C30 in myeloma patients. (c) 2007 Elsevier Ltd. All rights reserved.}},
  author       = {{Cocks, K. and Cohen, D. and Wisloff, F. and Sezerc, O. and Lee, S. and Hippe, E. and Gimsing, P. and Turesson, Ingemar and Hajek, R. and Smith, A. and Graham, L. and Phillips, A. and Stead, M. and Velikova, G. and Brown, J.}},
  issn         = {{1879-0852}},
  keywords     = {{QLQ-MY24; QLQ-MY20; QLQ-C30; questionnaires; validation; quality of life; multiple myeloma}},
  language     = {{eng}},
  number       = {{11}},
  pages        = {{1670--1678}},
  publisher    = {{Elsevier}},
  series       = {{European Journal of Cancer}},
  title        = {{An internadional field study of the reliability and validity of a disease-specfic questionnanire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma}},
  url          = {{http://dx.doi.org/10.1016/j.ejca.2007.04.022}},
  doi          = {{10.1016/j.ejca.2007.04.022}},
  volume       = {{43}},
  year         = {{2007}},
}